CNAT - Conatus Pharmaceuticals reports Q1 results May, 01 2020 04:07 PM Conatus Pharmaceuticals Conatus Pharmaceuticals (NASDAQ:CNAT): Q1 GAAP EPS of -$0.10.Cash, cash equivalents and marketable securities of $18MPress ReleaseMore news on: Conatus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, ,